Cancer stem cells and angiogenesis

International Journal of Developmental Biology

Volumn 55, Issue 4-5, 2011, Pages 477-482

  Zhao, Yue ^a   Bao, Qi ^a   Renner, Andrea ^a   Camaj, Peter ^a   Eichhorn, Martin ^a   Ischenko, Ivan ^a   Angele, Martin ^a   Kleespies, Axel ^a   Jauch, Karl Walter ^a   Bruns, Christiane ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Cancer stem cell; Cancer vascular niche microenvironment

Indexed keywords

BONE MORPHOGENETIC PROTEIN; NOTCH RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER STEM CELL; CELL ACTIVITY; CELL GROWTH; CELL RENEWAL; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; GLIOBLASTOMA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; STEM CELL NICHE;

EID: 79960982340     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103225yz     Document Type: Article

References (46)

1. AL-HAJJ, M., WICHA, M.S., BENITO-HERNANDEZ, A., MORRISON, S.J. and CLARKE, M.F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
2. ALITALO, K., TAMMELA, T. and PETROVA, T.V. (2005). Lymphangiogenesis in development and human disease. Nature 438: 946-953.
3. ANDROUTSELLIS-THEOTOKIS, A., LEKER, R.R., SOLDNER, F., HOEPPNER, D.J., RAVIN, R., POSER, S.W., RUEGER, M.A., BAE, S.K., KITTAPPA, R. and MCKAY, R.D. (2006). Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442: 823-826.
4. BAO, S.D., WU, Q.L., SATHORNSUMETEE, S., HAO, Y.L., LI, Z.Z., HJELMELAND, A.B., SHI, O., MCLENDON, R.E., BIGNER, D.D. and RICH, J.N. (2006). Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848.
5. BERGERS, G., HANAHAN, D. and COUSSENS, L.M. (1998). Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol 42: 995-1002.
6. BLOUSHTAIN-QIMRON, N., YAO, J., SNYDER, E.L., SHIPITSIN, M., CAMPBELL, L.L., MANI, S.A., HU, M., CHEN, H., USTYANSKY, V., ANTOSIEWICZ, J.E. et al. (2008). Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci USA 105: 14076-14081.
7. CALABRESE, C., POPPLETON, H., KOCAK, M., HOGG, T.L., FULLER, C., HAMNER, B., OH, E.Y., GABER, M.W., FINKLESTEIN, D., ALLEN, M. et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
8. CARMELIET, P. (2005). Angiogenesis in life, disease and medicine. Nature 438: 932-936.
9. CHEN, R., NISHIMURA, M.C., BUMBACA, S.M., KHARBANDA, S., FORREST, W.F., KASMAN, I.M., GREVE, J.M., SORIANO, R.H., GILMOUR, L.L., RIVERS, C.S. et al. (2010). A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17: 362-375.
10. CRNIC, I. and CHRISTOFORI, G. (2004). Novel technologies and recent advances in metastasis research. Int J Dev Biol 48: 573-581.
11. ECCLES, S.A. (2004). Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention. Int J Dev Biol 48: 583-598.
12. ESCUDIER, B., EISEN, T., STADLER, W.M., SZCZYLIK, C., OUDARD, S., SIEBELS, M., NEGRIER, S., CHEVREAU, C., SOLSKA, E., DESAI, A.A. et al. (2007). Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356: 125-134.
13. FAIVRE, S., DEMETRI, G., SARGENT, W. and RAYMOND, E. (2007). Molecular basis for sunitinib efficacy and future clinical development. Nat Rev Drug Discov 6: 734-745.
14. FOLKINS, C., MAN, S., XU, P., SHAKED, Y., HICKLIN, D.J. and KERBEL, R.S. (2007). Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 67: 3560-3564.
15. FOLKINS, C., SHKED, Y., MAN, S., TANG, T., LEE, C.R., ZHU, Z.P., HOFFMAN, R.M. and KERBEL, R.S. (2009). Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1. Cancer Res 69: 7243-7251.
16. GENTILE, A. and COMOGLIO, P.M. (2004). Invasive growth: a genetic program. Int J Dev Biol 48: 451-456.
17. GINESTIER, C., HUR, M.H., CHARAFE-JAUFFRET, E., MONVILLE, F., DUTCHER, J., BROWN, M., JACQUEMIER, J., VIENS, P., KLEER, C.G., LIU, S. et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
18. GRIDLEY, T. (2007). Notch signaling in vascular development and physiology. Development 134: 2709-2718.
19. HERMANN, P.C., HUBER, S.L., HERRLER, T., AICHER, A., ELLWART, J.W., GUBA, M., BRUNS, C.J. and HEESCHEN, C. (2007). Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323.
20. HIDA, K., HIDA, Y., AMIN, D.N., FLINT, A.F., PANIGRAHY, D., MORTON, C.C. and KLAGSBRUN, M. (2004). Tumor-associated endothelial cells with cytogenetic abnormalities. Cancer Res 64: 8249-8255.
21. HILLEN, F. and GRIFFIOEN, A.W. (2007). Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev 26: 489-502.
22. HOVINGA, K.E., SHIMIZU, F., WANG, R., PANAGIOTAKOS, G., VAN DER HEIJDEN, M., MOAYEDPARDAZI, H., SOFIA CORREIA, A., SOULET, D., MAJOR, T., MENON, J. et al. (2010). Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells Via an Endothelial Cell Intermediate. Stem Cells 28:1019-1029.
23. HURWITZ, H., FEHRENBACHER, L., NOVOTNY, W., CARTWRIGHT, T., HAINSWORTH, J., HEIM, W., BERLIN, J., BARON, A., GRIFFING, S., HOLMGREN, E. et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342.
24. KAUR, B., KHWAJA, F.W., SEVERSON, E.A., MATHENY, S.L., BRAT, D.J. and VAN MEIR, E.G. (2005). Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro-Oncology 7: 134-153.
25. KERBEL, R.S. (2008). Molecular origins of cancer: Tumor angiogenesis. N Engl J Med 358: 2039-2049.
26. KLONISCH, T., WIECHEC, E., HOMBACH-KLONISCH, S., ANDE, S.R., WESSELBORG, S., SCHULZE-OSTHOFF, K. and LOS, M. (2008). Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol Med 14: 450-460.
27. LAPIDOT, T., SIRARD, C., VORMOOR, J., MURDOCH, B., HOANG, T., CACERES-CORTES, J., MINDEN, M., PATERSON, B., CALIGIURI, M.A. and DICK, J.E. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
28. LI, X., LEWIS, M.T., HUANG, J., GUTIERREZ, C., OSBORNE, C.K., WU, M.F., HILSENBECK, S.G., PAVLICK, A., ZHANG, X., CHAMNESS, G.C. et al. (2008). Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679.
29. MANI, S.A., GUO, W., LIAO, M.J., EATON, E.N., AYYANAN, A., ZHOU, A.Y., BROOKS, M., REINHARD, F., ZHANG, C.C., SHIPITSIN, M. et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
30. MAROTTA, L.L. and POLYAK, K. (2009). Cancer stem cells: a model in the making. Curr Opin Genet Dev 19: 44-50.
31. OPDENAKKER, G. and VAN DAMME, J. (2004). The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines. Int J Dev Biol 48: 519-527.
32. PELLEGATTA, S., POLIANI, P.L., CORNO, D., MENGHI, F., GHIELMETTI, F., SUAREZ-MERINO, B., CALDERA, V., NAVA, S., RAVANINI, M., FACCHETTI, F. et al. (2006). Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66: 10247-10252.
33. PICCIRILLO, S.G., REYNOLDS, B.A., ZANETTI, N., LAMORTE, G., BINDA, E., BROGGI, G., BREM, H., OLIVI, A., DIMECO, F. and VESCOVI, A.L. (2006). Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765.
34. PLATE, K.H., BREIER, G., WEICH, H.A., MENNEL, H.D. and RISAU, W. (1994). Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520-529.
35. PLATE, K.H., BREIER, G., WEICH, H.A. and RISAU, W. (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848.
36. SANDLER, A., GRAY, R., PERRY, M.C., BRAHMER, J., SCHILLER, J.H., DOWLATI, A., LILENBAUM, R. and JOHNSON, D.H. (2006). Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355: 2542-2550.
37. SHAO, E.S., LIN, L., YAO, Y. and BOSTROM, K.I. (2009). Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood 114: 2197-2206.
38. SINGH, S.K., HAWKINS, C., CLARKE, I.D., SQUIRE, J.A., BAYANI, J., HIDE, T., HENKELMAN, R.M., CUSIMANO, M.D. and DIRKS, P.B. (2004). Identification of human brain tumour initiating cells. Nature 432: 396-401.
39. ST CROIX, B., RAGO, C., VELCULESCU, V., TRAVERSO, G., ROMANS, K.E., MONTGOMERY, E., LAL, A., RIGGINS, G.J., LENGAUER, C., VOGELSTEIN, B. et al. (2000). Genes expressed in human tumor endothelium. Science 289: 1197-1202.
40. VERMEULEN, L., SPRICK, M.R., KEMPER, K., STASSI, G. and MEDEMA, J.P. (2008). Cancer stem cells--old concepts, new insights. Cell Death Differ 15: 947-958.
41. VISVADER, J.E. and LINDEMAN, G.J. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
42. WICHA, M.S., LIU, S. and DONTU, G. (2006). Cancer stem cells: an old idea--a paradigm shift. Cancer Res 66: 1883-90; discussion 1895-1896.
43. XIONG, Y.Q., SUN, H.C., ZHANG, W., ZHU, X.D., ZHUANG, P.Y., ZHANG, J.B., WANG, L., WU, W.Z., QIN, L.X. and TANG, Z.Y. (2009). Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells. Clinical Cancer Res 15: 4838-4846.
44. YANG, X.R., XU, Y., YU, B., ZHOU, J., QIU, S.J., SHI, G.M., ZHANG, B.H., WU, W.Z., SHI, Y.H., WU, B. et al. (2010). High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59:953-962.
45. YAO, X.H., PING, Y.F., CHEN, J.H., XU, C.P., CHEN, D.L., ZHANG, R., WANG, J.M. and BIAN, X.W. (2008). Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. J Pathol 215: 369-376.
46. YU, F., YAO, H., ZHU, P., ZHANG, X., PAN, Q., GONG, C., HUANG, Y., HU, X., SU, F., LIEBERMAN, J. et al. (2007). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.